AVANIR PHARMACEUTICALS (AVNR)

[damoney]

This company is still in the infancy stage with a lot of room to grow. I’ve been in contact with a friend of mine, a physician, who is part of a group and they have not been approached by any sales reps from AVNR. BTW, she is excited about the product and the potential uses outside the scope of its original intent. All, I’m trying to convey is that sales reps possibly have not yet saturated their territories. And we still await the European market.
Patience is key here for any investor waiting to reap the full benefits.
JMHO
GLTA